Genset, a biotechnology company, was established in 1989 in Paris, France with Pascal Brandys as its first president.[1]
The company was listed on the NASDAQ and the Paris Bourse.[2]
History
Genset was listed on the NASDAQ and the Paris Bourse (now NYSE Euronext) in 1996.[3] Genset rapidly became the European flagship company[3] in the field of genomics and became the second-largest biotechnology company in Europe in 1999.